Last reviewed · How we verify
NCT03658018: CLBP
Intraosseous Basivertebral Nerve Ablation for Treatment of Chronic Low Back Pain
NA trial testing Intracept System Ablation in Chronic Low Back Pain. Withdrawn.
12 July 2019
Quick facts
| Lead sponsor | Relievant Medsystems, Inc. |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 2 January 2019 |
| Primary completion | 12 July 2019 |
| Estimated completion | 12 July 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Intracept System Ablation
Conditions studied
- Chronic Low Back Pain — all drugs for Chronic Low Back Pain →
Sponsor
Relievant Medsystems, Inc.
Who can join
Adults 25 to 70, any sex, with Chronic Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective of study is to evaluate the procedural success rate, clinical effectiveness, and heath-economic profile using the Intercept Intraosseous Nerve Ablation System in adult subjects with chronic low back pain in the post-market setting
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03658018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intracept System Ablation
Trials testing the same drug.
- NCT03630133 — Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain · NA · withdrawn
Other recruiting trials for Chronic Low Back Pain
Currently open trials in the same condition.
- NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
- NCT06419439 — Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression · Phase 2 · recruiting
- NCT07241559 — Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain · NA · recruiting
- NCT07132762 — The Effect of ESWT Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Bac · NA · recruiting
Other Relievant Medsystems, Inc. trials
Trials by the same sponsor.
- NCT04449835 — The Intracept Global Registry ( TIGR ) - Pilot Study · terminated
- NCT03997825 — Five-Plus Year Follow-Up of SMART Randomized Controlled Trial · completed
- NCT03630133 — Intraosseous Basivertebral Nerve Ablation for the Treatment of Chronic Low Back Pain · NA · withdrawn
- NCT03266107 — Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain · NA · completed
- NCT03246061 — INTRACEPT: Prospective, Randomized, Multi-center Study Intraosseous Basivertebral Nerve Ablation for Treatment of CLBP · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03658018 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Relievant Medsystems, Inc.
- Last refreshed: 15 August 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03658018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing